Citation
Select
Sutherland ER, Allmers H, Ayas NT, Venn AJ, Martin RJ
Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis
Thorax. 2003 Nov;58(11):937-41
Citation
Select
Valsartan in Acute Myocardial Infarction Trial (VALIANT) Investigators; Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Kober L, Maggioni AP, Solomon SD, Swedberg K, Van de Werf F, White H, Leimberger JD, Henis M, Edwards S, Zelenkofske S, Sellers MA, Califf RM
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
N Engl J Med. 2003 Nov 13;349(20):1893-906
Citation
Select
Richard C, Warszawski J, Anguel N, Deye N, Combes A, Barnoud D, Boulain T, Lefort Y, Fartoukh M, Baud F, Boyer A, Brochard L, Teboul JL; French Pulmonary Artery Catheter Study Group
Early use of the pulmonary artery catheter and outcomes in patients with shock and acute respiratory distress syndrome: a randomized controlled trial
JAMA. 2003 Nov 26;290(20):2713-20
Citation
Select
Chastre J, Wolff M, Fagon JY, Chevret S, Thomas F, Wermert D, Clementi E, Gonzalez J, Jusserand D, Asfar P, Perrin D, Fieux F, Aubas S; PneumA Trial Group
Comparison of 8 vs 15 days of antibiotic therapy for ventilator-associated pneumonia in adults: a randomized trial
JAMA. 2003 Nov 19;290(19):2588-98
Citation
Select
Lubetsky A, Yonath H, Olchovsky D, Loebstein R, Halkin H, Ezra D
Comparison of oral vs intravenous phytonadione (vitamin K1) in patients with excessive anticoagulation: a prospective randomized controlled study
Arch Intern Med. 2003 Nov 10;163(20):2469-73